Innovations in Oncology 2021
Tumours evolve: can we predict the next move?
Tumour evolution is far more important than it was previously realised. It is usually the reason why tumours are so hard to treat. Traditionally, cancer development was seen as resulting in a relatively homogeneous tumour mass. In this scenario, cancer treatment would be relatively straightforward – if you can target one cancer cell you can … Continued
Innovations in Oncology Q4 2021
Protected: Optimising clinical trials for greater inclusiveness in cancer care
There is no excerpt because this is a protected post.
A liver cancer diagnosis is devastating – but SIRT can help
For the 5,000 people in the UK that are diagnosed with primary liver cancer or hepatocellular carcinoma (HCC), treatment choices have been severely limited. Now there’s a new option. The British Liver Trust has continued to work with the National Institute for Health and Care Excellence (NICE) during its examination into the use of selective … Continued